PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | May 07 '24 | Sale | 32.82 | 175 | 5,744 | 59,813 | May 08 05:20 PM | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Apr 19 '24 | Sale | 24.89 | 3,361 | 83,669 | 225,807 | Apr 22 05:20 PM | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Apr 17 '24 | Sale | 25.14 | 1,307 | 32,851 | 229,168 | Apr 19 05:20 PM | Pauwels Eric | CHIEF EXECUTIVE OFFICER | Apr 17 '24 | Sale | 25.14 | 787 | 19,781 | 67,694 | Apr 19 05:20 PM | Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Apr 02 '24 | Sale | 28.37 | 526 | 14,923 | 59,988 | Apr 04 05:16 PM | Boulding Mark Elliott | EXEC. VP AND CLO | Jan 30 '24 | Sale | 27.25 | 794 | 21,637 | 71,189 | Feb 01 04:17 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 30 '24 | Sale | 27.25 | 618 | 16,841 | 61,202 | Feb 01 04:18 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | Jan 30 '24 | Sale | 27.25 | 366 | 9,974 | 44,181 | Feb 01 04:16 PM | Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Jan 30 '24 | Sale | 27.25 | 318 | 8,666 | 35,528 | Feb 01 04:15 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 30 '24 | Sale | 27.25 | 28 | 763 | 3,706 | Feb 01 04:18 PM | Jacobson Allan Steven | Director | Jan 22 '24 | Option Exercise | 27.05 | 10,000 | 270,500 | 22,348 | Jan 24 04:30 PM | Jacobson Allan Steven | Director | Jan 22 '24 | Sale | 27.38 | 10,000 | 273,804 | 12,348 | Jan 24 04:30 PM | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Jan 09 '24 | Sale | 29.01 | 5,443 | 157,928 | 160,475 | Jan 10 04:08 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | Jan 09 '24 | Sale | 29.01 | 2,065 | 59,916 | 44,547 | Jan 10 04:09 PM | Boulding Mark Elliott | EXEC. VP AND CLO | Jan 09 '24 | Sale | 29.01 | 1,938 | 56,231 | 71,983 | Jan 10 04:04 PM | Utter Christine Marie | SVP, FINANCE & CAO | Jan 09 '24 | Sale | 29.01 | 1,653 | 47,961 | 35,846 | Jan 10 04:11 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 09 '24 | Sale | 29.01 | 1,521 | 44,132 | 61,820 | Jan 10 04:03 PM | Golden Lee Scott | CHIEF MEDICAL OFFICER | Jan 09 '24 | Sale | 29.01 | 1,225 | 35,543 | 37,914 | Jan 10 04:06 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 09 '24 | Sale | 29.01 | 100 | 2,901 | 3,734 | Jan 10 04:03 PM | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Jan 08 '24 | Sale | 28.64 | 2,237 | 64,068 | 165,918 | Jan 10 04:08 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | Jan 08 '24 | Sale | 28.64 | 1,569 | 44,937 | 46,612 | Jan 10 04:09 PM | Boulding Mark Elliott | EXEC. VP AND CLO | Jan 08 '24 | Sale | 28.64 | 1,457 | 41,729 | 73,921 | Jan 10 04:04 PM | SCHMERTZLER MICHAEL | Director | Jan 08 '24 | Sale | 27.81 | 1,500 | 41,715 | 115,266 | Jan 10 04:10 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 08 '24 | Sale | 28.64 | 1,236 | 35,399 | 63,341 | Jan 10 04:03 PM | Utter Christine Marie | SVP, FINANCE & CAO | Jan 08 '24 | Sale | 28.64 | 1,188 | 34,025 | 37,499 | Jan 10 04:11 PM | Golden Lee Scott | CHIEF MEDICAL OFFICER | Jan 08 '24 | Sale | 28.64 | 775 | 22,196 | 39,139 | Jan 10 04:06 PM | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jan 08 '24 | Sale | 28.64 | 53 | 1,518 | 3,834 | Jan 10 04:03 PM | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Jan 05 '24 | Sale | 27.15 | 10,107 | 274,393 | 168,155 | Jan 09 04:29 PM | Gravier Pierre | CHIEF FINANCIAL OFFICER | Dec 12 '23 | Buy | 25.81 | 7,700 | 198,736 | 33,700 | Dec 14 04:38 PM | Young Alethia | Director | Sep 06 '23 | Option Exercise | 27.85 | 11,666 | 324,898 | 16,067 | Sep 08 04:02 PM | Young Alethia | Director | Sep 06 '23 | Sale | 39.86 | 11,666 | 464,972 | 9,067 | Sep 08 04:02 PM | SCHMERTZLER MICHAEL | Director | Jun 07 '23 | Sale | 44.86 | 1,000 | 44,860 | 116,766 | Jun 09 04:03 PM | Reeve Emma | Director | May 23 '23 | Option Exercise | 33.38 | 2,652 | 88,520 | 8,602 | May 24 04:12 PM | Reeve Emma | Director | May 23 '23 | Sale | 59.53 | 2,652 | 157,885 | 7,200 | May 24 04:12 PM | Reeve Emma | Director | May 22 '23 | Option Exercise | 33.37 | 7,116 | 237,484 | 11,148 | May 24 04:12 PM | Reeve Emma | Director | May 22 '23 | Sale | 59.53 | 7,116 | 423,630 | 7,200 | May 24 04:12 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | May 22 '23 | Sale | 59.01 | 2,013 | 118,791 | 47,553 | May 23 04:05 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | May 19 '23 | Sale | 58.96 | 6,403 | 377,491 | 49,566 | May 23 04:05 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | May 18 '23 | Sale | 58.71 | 788 | 46,267 | 55,969 | May 19 04:04 PM | Pauwels Eric | CHIEF BUSINESS OFFICER | May 17 '23 | Sale | 58.50 | 8,048 | 470,822 | 56,757 | May 19 04:04 PM |
|